X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/abbisko-therapeutics-announces-that-us-fda-has-granted-fast-track-designation-for-its-csf-1r-inhibitor-pimicotinib-absk021-302014220.html
https://www.prnewswire.com/news-releases/87-5-orr--abbisko-presented-two-clinical-updates-of-pimicotinib-at-the-2023-ctos-annual-meeting-301979448.html
https://www.prnewswire.com/news-releases/abbisko-will-debut-two-blockbuster-clinical-research-results-at-the-2023-european-society-for-medical-oncologyesmo-301957550.html
https://www.prnewswire.com/news-releases/abbisko-presented-two-preclinical-research-results-at-the-35th-international-molecular-targets-and-cancer-treatment-conference-eortc-nci-aacr-301957292.html
https://www.clinicaltrialsarena.com/news/abbisko-updated-results-tgct-phase-ib/
https://www.prnewswire.com/news-releases/77-4-orr-abbisko-to-present-the-updated-clinical-phase-ib-data-of-pimicotinib-absk021-at-the-2023-asco-annual-meeting-301835716.html
https://www.prnewswire.com/news-releases/abbisko-presents-the-research-results-of-5-programs-at-the-2023-aacr-annual-meeting-301797704.html
https://endpts.com/shanghais-abbisko-out-licenses-egfr-candidate-in-nine-figure-deal/
Market Place
Share 
